Opinion: CVS’ drug-price plan lets pharma off too easy

CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
NEW YORK - The pharmacy benefit management business is under attack. And these middlemen of the arcane United States drug-pricing system are preparing their defenses.…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

- Advertisement -